Ligand-receptor interaction modelling using PET imaging

Ligand-receptor interaction modelling using PET imaging

Bibliographic Details
Main Author:	Zamuner, Stefano
Published:	City University London 2003
Subjects:	616 Positron emission tomography
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274523

Similar Items

Characteristics of Tau and Its Ligands in PET Imaging
by: Ryuichi Harada, et al.
Published: (2016-01-01)

Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising
by: Sandeep S. V. Golla, et al.
Published: (2017-04-01)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020-10-01)

PET Imaging Radiotracers of Chemokine Receptors
by: Santosh R. Alluri, et al.
Published: (2021-08-01)

PET Imaging of Microglial Activation—Beyond Targeting TSPO
by: Bieneke Janssen, et al.
Published: (2018-03-01)

Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
by: Rareş-Petru Moldovan, et al.
Published: (2017-04-01)

Reconstruction of PET Images Using Cross-Entropy and Field of Experts
by: Jose Mejia, et al.
Published: (2019-01-01)

PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
by: Santosh Reddy Alluri, et al.
Published: (2020-09-01)

Typical cerebral metabolic patterns in various types of dementia: an SPM analysis of 18F-FDG PET images
by: Rui-xue CUI, et al.
Published: (2014-04-01)

t-Bu2SiF-Derivatized D2-Receptor Ligands: The First SiFA-Containing Small Molecule Radiotracers for Target-Specific PET-Imaging
by: Björn Wängler, et al.
Published: (2011-09-01)

Influence of X-ray computed tomography (CT) exposure and reconstruction parameters on positron emission tomography (PET) quantitation
by: Ivan Ho Shon, et al.
Published: (2020-10-01)

Deep-Learning Based Positron Range Correction of PET Images
by: Joaquín L. Herraiz, et al.
Published: (2021-12-01)

PET Molecular Probes Targeting Folate Receptor
by: YIN Ji-lin1;WANG Cheng2;WANG Xin-lu1
Published: (2016-08-01)

18 F-FDG PET-CT for Staging of Conjunctival Melanoma
by: Andres Damian, et al.
Published: (2013-01-01)

PET/CT in Multiple Myeloma: Beyond FDG
by: Federica Matteucci, et al.
Published: (2021-01-01)

Characterization of [18F]flutemetamol binding properties : A β-amyloid PET imaging ligand
by: Heurling, Kerstin
Published: (2015)

The role of PET imaging in the evaluation of prognosis in patients with chronicdisorders of consciousness
by: Jing ZHANG, et al.
Published: (2015-12-01)

Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care
by: Vandana K Dhingra, et al.
Published: (2015-10-01)

Progress of PET Imaging Agents for Cardiovascular Diseases
by: MA Hui1;LIANG Hong1;XU Wan-bang2;TANG Gang-hua1
Published: (2018-04-01)

Simultaneous PET/MRI: Impact on cancer management-A comprehensive review of cases
by: Amarnath Jena, et al.
Published: (2014-05-01)

Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT
by: Martina Sollini, et al.
Published: (2016-07-01)

The 18F-FDG PET scan in oncology
by: T Thientunyakit
Published: (2007-12-01)

PET/CT: Current status in India
by: Venkatesh Rangarajan, et al.
Published: (2008-10-01)

The effect of fasting on Positron Emission Tomography (PET) imaging
by: Elham Dolat, et al.
Published: (2014-12-01)

Molecular Imaging with PET/CT in Oncology
by: Pejman Farde esfehani, et al.
Published: (2012-04-01)

Parametric PET Image Reconstruction via Regional Spatial Bases and Pharmacokinetic Time Activity Model
by: Naoki Kawamura, et al.
Published: (2017-11-01)

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma
by: Tibor Vag, et al.
Published: (2018-09-01)

Fully Automated Synthesis of Novel TSPO PET Imaging Ligand [<sup>18</sup>F]Fluoroethyltemazepam
by: Dario Fiorenza, et al.
Published: (2021-04-01)

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
by: Paul Windisch, et al.
Published: (2020-09-01)

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
by: Tetsuro Tago, et al.
Published: (2018-01-01)

Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
by: Melissa C. Wren, et al.
Published: (2018-05-01)

18F-sodium fluoride PET-CT hybrid imaging of the lumbar facet joints: Tracer uptake and degree of correlation to CT-graded arthropathy
by: Marc C Mabray, et al.
Published: (2016-01-01)

Neuropsychiatric symptoms and PET imaging characteristics in patients with Parkinson-plus syndromes
by: Miao ZHANG, et al.
Published: (2017-01-01)

The effect of fasting on Positron Emission Tomography (PET) imaging (ahead of publication)
by: Elham Dolat, et al.
Published: (2014-12-01)

18F-FLOURODEOXYGLUCOSE (18FDG) POSITRON-EMISSION TOMOGRAPHY (PET) AS IMAGING MODALITIES ON THYROID CANCER MANAGEMENT
by: I Putu Ary Wismayana, et al.
Published: (2013-07-01)

Design, construction and validation of a combined PET/CT tomograph for clinical oncology
by: Beyer, Thomas
Published: (1999)

Recent progress of PET in Alzheimer's disease
by: Na NIU, et al.
Published: (2014-03-01)

A Formula to Calculate the Threshold for Radiotherapy Targets on PET Images: Simulation Study
by: Jianhua Geng, et al.
Published: (2020-10-01)

PET/CT in renal and bladder cancers
by: Balenović Antonija, et al.
Published: (2012-01-01)

Pattern of FDG-PET uptake in lipoid pneumonia simulating lung cancer
by: Kensuke Nakagawara, et al.
Published: (2020-01-01)